The Hartford HealthCare Cancer (HHC) Institute is part of the HHC system, which includes a major tertiary/quaternary teaching hospital; four community hospitals; a large primary care physician practice group; a regional home-care system; rehabilitation services; a behavioral health network; senior health services, including skilled-nursing and assisted-living facilities; and a statewide clinical laboratory operation. HHC treats more than 6,000 new cases of cancer annually.
Comprehensive, Coordinated Care
The HHC Cancer Institute was established to deliver high-quality, standardized, multidisciplinary and coordinated care to all HHC cancer patients, no matter where in the HHC system a patient receives care.
Full Continuum of Specialty Services
The institute model of care provides all the types of expert care a patient may need for his or her treatment and overall quality of life. For cancer patients, this includes oncologists, nurses, pharmacists and other care givers. Site-specific, cancer-care teams of oncologists, surgeons, radiologists, pathologists, nurses, researchers and others meet weekly to discuss new patients. A team is involved in every patient’s care.
World-Class Expertise, Close to Home
Through its membership in the MSK Cancer Alliance, the HHC Cancer Institute will expand and enhance well-established cancer programs, services, and research across the HHC system and provider network. The HHC Cancer Institute will implement MSK standards of care.
Unmatched Access to innovation
HHC Cancer Institute patients will have unprecedented access to MSK clinical trials conducted by HHC physicians in HHC communities where patients live.
About Memorial Sloan Kettering Cancer Alliance
The Memorial Sloan Kettering Cancer Alliance is an initiative designed to collaboratively guide community providers toward state-of-the-art cancer care. Its overarching goal is to improve the lives of cancer patients through dynamic partnerships with local care providers.
The concept of the MSK Cancer Alliance emerged out of a growing awareness that community oncologists deliver the vast majority of cancer care in the United States, but advances in treatment and research can take years to reach those patients. Collaborative partnerships not only help meet a rising need for access to high-quality cancer care and clinical trials, but improve patient outcomes while also giving MSK an opportunity to understand from our partners how care is best delivered in the community setting.
Central to the Memorial Sloan Kettering Cancer Alliance is a mutual willingness to learn from one another and a shared vision of our partnership as an ongoing endeavor tailored to meet the unique needs of our members and the communities they serve.
Learn more about the Memorial Sloan Cancer Center Alliance here.
Learn more about Memorial Sloan Kettering Cancer Center here.